器官移植2025，Vol.16Issue(3)：338-349,12.DOI:10.12464/j.issn.1674-7445.2025100
2024年中国肝移植基础研究年度盘点
Annual review of liver transplantation basic research of China in 2024
摘要
Abstract
Liver transplantation has currently become an important treatment for patients with end-stage liver disease or hepatocellular carcinoma(HCC),significantly improving patients'prognosis.However,liver transplantation still facing many challenges,such as donor sources,liver preservation technology,transplant rejection,biliary complications and postoperative tumor recurrence after HCC liver transplantation,which urgently need to be solved and optimized.With the development of new technologies,liver transplantation in our country is facing new opportunities and challenges.Domestic research teams actively respond to the needs of the times and continuously promote innovation and breakthroughs in the basic research of liver transplantation.This article reviews the cutting-edge progress in the field of basic liver transplantation research in 2024 and evaluates the important research achievements obtained by Chinese research teams in this field.The systematic sorting out of these research advances not only helps to promote the integration of Chinese characteristic liver transplantation research into the international academic system and the docking of Chinese liver transplantation research with the global forefront,but also helps researchers and clinical surgeons to fully understand the current status of basic liver transplantation research in China,provides a clear direction for future basic research,and thus promotes the vigorous development of Chinese liver transplantation cause.关键词
肝移植/供者来源/劈离式肝移植/肝再生/缺血-再灌注损伤/肝细胞癌/胆道并发症/排斥反应Key words
Liver transplantation/Donor source/Split liver transplantation/Liver regeneration/Ischemia-reperfusion injury/Hepatocellular carcinoma/Biliary complication/Rejection分类
医药卫生引用本文复制引用
陈德盛,叶林森,刘炜,杨扬..2024年中国肝移植基础研究年度盘点[J].器官移植,2025,16(3):338-349,12.基金项目
国家重点研发计划(2024YFA1107200) （2024YFA1107200）
国家自然科学基金(U24A20655、82172585) （U24A20655、82172585）
广州市科技计划项目(2024A03J0273) （2024A03J0273）
广州地区临床高新、重大、特色技术项目(2023P-GX05) （2023P-GX05）
